Peng and colleagues demonstrated that lncRNA GAS5 inhibited RA inflammation in synovial tissue by controlling HDAC4 by miR-128-3p, which suggested that GAS5/miR-128-3p/HDAC4 axis had therapeutic potential in RA treatment [7]. Here, GAS5 is linked to rheumatoid arthritis.